News & Analysis on Clinical Trial Services & Contract Research And Development
In the UK, the House of Commons Health Committee is to undertake a broad-ranging inquiry into the influence of the pharmaceutical industry on health policy, to look for conflicts between the need for new drugs and commercial interests, reports Phil...
A new treatment for cancer that destroys tumours by heating them from the inside has shown promise in animal studies conducted at Rice University in the US, writes Phil Taylor.
A remote controlled camera system that provides continuous monitoring of a key processing machine has achieved a hike in operating efficacy at active pharmaceutical ingredient (API) and fine chemicals company Macfarlan Smith.
UK biotechnology company Xenova has been given regulatory approval for a manufacturing facility for clinical trial materials for its own use, as well as for its clients.
Rudolf Hanko, formerly head of the fine chemicals business unit at Bayer, has joined Degussa as head of the company's exclusive synthesis business line, part of Degussa's Exclusive Synthesis & Catalysts business unit.
Affymetrix has extended the range of custom microarrays it offers to customers with the launch of the NimbleExpress Array Programme, which caters for users that require fewer units.